Literature DB >> 3889228

Homoharringtonine as a new antileukemic agent.

T Ohnuma, J F Holland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889228     DOI: 10.1200/JCO.1985.3.5.604

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation.

Authors:  Shangting Han; Fangyou Lin; Yucheng Qi; Cong Liu; Linxiang Zhou; Yuqi Xia; Kang Chen; Ji Xing; Zilin Liu; Weimin Yu; Yunlong Zhang; Xiangjun Zhou; Ting Rao; Fan Cheng
Journal:  Oxid Med Cell Longev       Date:  2022-04-25       Impact factor: 7.310

2.  Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.

Authors:  L J Wilkoff; D A Dulmadge; W R Laster; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Etoposide-resistant human colon and lung adenocarcinoma cell lines exhibit sensitivity to homoharringtonine.

Authors:  L J Wilkoff; E A Dulmadge; G Vasanthakumar; J P Donahue
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study.

Authors:  M A Runge-Morris; M S Kies; E Vokes; R Blough; L Weidner; R Knop; K Rowland
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

5.  Isoharringtonine Induces Apoptosis of Non-Small Cell Lung Cancer Cells in Tumorspheroids via the Intrinsic Pathway.

Authors:  Ji Hae Lee; So-Young Park; Wonbin Hwang; Jee Young Sung; Myoung-Lae Cho; Jaegal Shim; Yong-Nyun Kim; Kyungsil Yoon
Journal:  Biomolecules       Date:  2020-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.